Simple breathing therapy may cut pneumonia risk after hip fracture surgery

NCT ID NCT07189260

Recruiting now Prevention Sponsor: University Hospital Bispebjerg and Frederiksberg Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether using a positive expiratory pressure (PEP) device before and after hip fracture surgery can prevent hospital-acquired pneumonia. About 566 patients will either receive the PEP therapy plus standard care or standard care alone. The goal is to see if this simple breathing exercise reduces lung infections, a common and serious complication after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: positive expiratory pressure (PEP) device
What this could lead to: If it works, this simple breathing therapy could become a standard way to prevent pneumonia after hip fracture surgery, reducing complications and deaths.
What could go wrong: This is a single trial with 566 participants, and the therapy requires active patient cooperation, which may be hard for some. It may not show a clear benefit over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP FRACTURES (ICD-10 72.01-72.2) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Healthcare-Associated Pneumonia hip fracture osteoporosis pneumonia nosocomial infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIP FRACTURES (ICD-10 72.01-72.2)

Contacts and locations

Locations

Bispebjerg & Frederiksberg Hospital
RECRUITING

Copenhagen, 2400, Denmark
Herlev & Gentofte Hospital
RECRUITING

Herlev, 2730, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.